Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.2 USD -4.16% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Revenue Breakdown

Breakdown by Geography
Supernus Pharmaceuticals Inc

Not Available

Breakdown by Segments
Supernus Pharmaceuticals Inc

Total Revenue: 607.5m USD
100%
Product: 573.9m USD
94.5%
Qelbree: 140.2m USD
23.1%
Gocovri: 119.6m USD
19.7%
Oxtellar X R: 113.4m USD
18.7%
Trokendi Xr: 94.3m USD
15.5%
Apokyn: 75.1m USD
12.4%
Royalty: 33.6m USD
5.5%
Manufactured Product, Other: 31.3m USD
5.1%
Show More
Show Less

See Also

Discover More